#Jeff webber dirt work pratt kansas trial
Final results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alpha-2b for reducing recurrence of superficial bladder cancer. Joudi FN, O’Donnell MA and the National BCG-Interferon Phase 2 Investigator Group.The Impact of provider volume on outcomes from urologic cancer therapy. The volume-outcome relationship in urologic cancer surgery. Second-line intravesical therapy versus cystectomy for bacillus Calmette-Guerin (BCG) failures. Fluorescence cystoscopy and bladder surveillance. Testicular rupture secondary to paintball injury. Isolated testicular vasculitis presenting as tumor-like lesion. Joudi FN, Austin JC, Vogelgesang SA, Jensen CS.Contemporary management of superficial bladder cancer in the United States: a pattern of care analysis. Joudi FN, Smith BJ, O’Donnell MA, Konety B.Fellow, Royal College of Surgeons of Canada.Urologic Oncology Fellowship: University of Iowa, Iowa City, Iowa Residency: University of Toronto, Toronto, Ontario, Canada and University of Iowa, Iowa City, Iowa Medical Degree: American University of Beirut, Lebanon Joudi is a fellow of the American College of Surgeons, a fellow of Royal College of Surgeons of Canada and board certified by the American Board of Urology. He completed a fellowship in urologic oncology at the University of Iowa and then joined the Department of Urology there as an assistant professor. Louis, MO, and completed residencies in urology at the University of Toronto, in Toronto, Ontario, Canada, and at the University of Iowa, in Iowa City, Iowa. He completed his internship in internal medicine at St. Joudi received his medical degree from the American University of Beirut, in Beirut, Lebanon.
0 kommentar(er)
